Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line (Q31031641)

28 June 2017

title

Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line (English)

1 reference

28 June 2017

1 reference

1

Jin-Jian Lu

1 reference

28 June 2017

Si-Meng Chen

2

1 reference

28 June 2017

Jian Ding

series ordinal

3

1 reference

28 June 2017

Ling-Hua Meng

series ordinal

4

1 reference

28 June 2017

publication date

30 September 2011

1 reference

Molecular and Cellular Biochemistry

28 June 2017

published in

1 reference

28 June 2017

volume

360

1 reference

28 June 2017

issue

1-2

1 reference

28 June 2017

page(s)

329-337

1 reference

The history of qing hao in the Chinese materia medica

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Molecular modes of action of artesunate in tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Two-dimensional gel electrophoresis maps of the proteome and phosphoproteome of primitively cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

The roles of HSP27 and annexin II in resistance to UVC-induced cell death: comparative studies of the human UVC-sensitive and -resistant cell lines RSa and APr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Drug discovery in the ubiquitin-proteasome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1072-2

Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.

21 January 2018

1 reference

12 December 2020

Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer

1 reference

12 December 2020

Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway

1 reference

12 December 2020

Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.

1 reference

12 December 2020

Caspase-8 preferentially senses the apoptosis-inducing action of NG-18, a Gambogic acid derivative, in human leukemia HL-60 cells

1 reference

12 December 2020

10.1007/S11010-011-1072-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1031812405

0 references

1 reference